Asylia Diagnostics BV
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-08-22
- Employees
- 1
- Market Cap
- -
- Website
- http://www.asyliadx.com
Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors
- Conditions
- MelanomaLung Cancer
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Asylia Diagnostics BV
- Target Recruit Count
- 400
- Registration Number
- NCT04860076
- Locations
- 🇧🇪
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
© Copyright 2025. All Rights Reserved by MedPath